United States Cheek Augmentation Market By Product (Derma Fillers, Implant, Others), By Technique (Surgical, Non-surgical), By End User (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others), By Region and Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 1.27 Billion
CAGR (2026-2031)	7.95%
Fastest Growing Segment	Non Surgical
Largest Market	Mid-West
Market Size (2031)	USD 2.01 Billion

Market Overview

The United States Cheek Augmentation Market will grow from USD 1.27 Billion in 2025 to USD 2.01 Billion by 2031 at a 7.95% CAGR. Cheek augmentation encompasses cosmetic procedures aimed at enhancing the volume, contour, and definition of the midfacial region. These interventions range from surgical methods like implant placement or autologous fat transfer to non-surgical options, predominantly involving injectable dermal fillers. The market's growth is primarily supported by an increasing aesthetic consciousness among the population, a desire for a more youthful facial appearance, and advancements in minimally invasive techniques that offer reduced recovery times. Furthermore, the rising influence of social media in shaping beauty standards and an expanding aging demographic seeking solutions for age-related volume loss contribute significantly to market expansion.

The United States cheek augmentation market demonstrates robust activity across both surgical and non-surgical segments. According to the American Society of Plastic Surgeons, in 2024, 9,130 cheek implant procedures were performed. Concurrently, hyaluronic acid dermal fillers, frequently utilized for non-surgical cheek enhancement, saw 5,331,426 procedures performed in 2024, according to the American Society of Plastic Surgeons. A significant challenge impeding market expansion is the temporary nature of many non-surgical procedures, necessitating repeat treatments, which contributes to ongoing financial commitment for patients.

Key Market Drivers

Growing Demand for Cosmetic Aesthetic Procedures Drives Cheek Augmentation Market
The increasing demand for cosmetic aesthetic procedures serves as a primary driver within the United States cheek augmentation market, reflecting a broad societal shift towards prioritizing personal appearance and a more youthful facial aesthetic. Consumers are increasingly seeking interventions to enhance facial contour and address signs of aging, spurred by factors like heightened self-awareness and the influence of media. This sustained interest in enhancing facial features contributes significantly to the market's expansion. According to the American Academy of Facial Plastic and Reconstructive Surgery, in its "2025 Annual Survey," there was a projected 19 percent increase in facial procedures nationwide, totaling an estimated 1.6 million procedures in 2025. This trend underscores a growing willingness among the population to invest in cosmetic enhancements for a rejuvenated look, including improvements to the midfacial region.

Rising Preference for Minimally Invasive, Non-Surgical Cheek Augmentation
The rising preference for minimally invasive techniques further propels the cheek augmentation market, as patients increasingly favor options that offer reduced downtime, lower procedural risks, and more subtle, natural-looking outcomes compared to traditional surgical methods. Injectable dermal fillers, a cornerstone of non-surgical cheek enhancement, exemplify this shift by providing immediate results with minimal recovery. This inclination towards less intrusive interventions is widespread across demographics. Supporting this, the American Academy of Facial Plastic and Reconstructive Surgery's "2025 Annual Survey" also reported that non-invasive treatments accounted for an impressive 80 percent of all procedures performed by its members in 2025. Overall, the US medical spa industry, a key provider of many non-surgical aesthetic services, was projected to exceed $20 billion in 2025, according to the American Med Spa Association.

Download Free Sample Report

Key Market Challenges

Ongoing Costs From Temporary Treatments Limit Market Growth
The temporary nature of many non-surgical procedures represents a significant impediment to the sustained growth of the United States cheek augmentation market. While these interventions offer aesthetic enhancements, their transient effects necessitate repeat treatments, thereby imposing an ongoing financial commitment on patients. This continuous expenditure can eventually deter some individuals from pursuing or maintaining non-surgical cheek augmentation, limiting the market's overall expansion. Patients must factor in not just the initial cost but also the cumulative expense of maintaining their desired results over time.

Dominance of Noninvasive Treatments Drives Recurrent-Cost Burden
This cyclical demand for repeat treatments, particularly for highly popular non-surgical methods, can translate into a substantial financial burden that outweighs the perceived benefits for a segment of the population. For example, according to the American Academy of Facial Plastic and Reconstructive Surgery's 2025 Annual Survey, noninvasive treatments, which include fillers, constituted 80 percent of all procedures performed by its members. The widespread reliance on these temporary solutions means a large portion of the market is subject to this challenge, hindering deeper market penetration and patient loyalty due to the cumulative cost associated with maintaining results.

Key Market Trends

Biostimulatory Injectables Drive U.S. Cheek Augmentation Growth
A significant trend influencing the United States cheek augmentation market is the increasing adoption of biostimulatory injectables. Unlike traditional dermal fillers that primarily add volume, biostimulatory agents work by stimulating the body's natural collagen production, offering gradual and more regenerative results. This approach appeals to patients seeking long-term improvements in skin quality and structural support rather than immediate, often temporary, volume enhancement. This shift underscores a growing preference for treatments that enhance the skin's intrinsic properties. According to Galderma's financial results reported on April 23, 2026, for the first quarter of 2026, its Fillers & Biostimulators product category achieved net sales of 284 million USD, demonstrating a 14.0% year-on-year growth at constant currency, with particularly strong growth observed in the U.S..

Rising Preference for Natural-Looking, Balanced Augmentation
Another prominent trend shaping the market is the heightened demand for natural-looking augmentation outcomes. Patients are increasingly seeking subtle enhancements that preserve their individual facial characteristics and avoid an "overdone" or artificial appearance. This preference guides practitioners toward techniques and product selections that integrate harmoniously with existing facial anatomy, focusing on balance and refined contours. This cultural shift prioritizes authenticity and discretion in aesthetic results. Reflecting this, a NewBeauty report published on July 25, 2025, indicated that 69.3% of patients consider "natural-looking" to be the most important factor when choosing a neurotoxin, and nearly 70% are more inclined to book filler treatments if the discussion centers on facial balancing.

Segmental Insights

Non-Surgical Cheek Augmentation: Fastest-Growing Segment Driven by Dermal Fillers and FDA Clearances
In the United States Cheek Augmentation Market, the non-surgical segment is experiencing rapid expansion as the fastest-growing category. This accelerated growth is primarily attributed to a strong consumer preference for minimally invasive aesthetic procedures that offer immediate results with significantly reduced downtime compared to traditional surgical interventions. Patients increasingly favor options like dermal fillers due to their lower associated risks and the ability to achieve customizable, reversible enhancements. The introduction of advanced filler formulations, alongside clearances from regulatory bodies such as the U.S. Food and Drug Administration (FDA) for specific cheek enhancement products, further bolsters consumer confidence and market uptake. This shift reflects a broader trend towards convenient, effective aesthetic solutions.

Regional Insights

Midwest: Region of Significant Influence in the U.S. Cheek Augmentation Market
The United States Cheek Augmentation Market reveals the Midwest as a region of significant influence, primarily driven by its rapid growth in aesthetic procedure demand. This area demonstrates some of the fastest growth in consumer interest for cosmetic enhancements, signifying its emerging prominence within the national market landscape. This strong expansion is logically attributed to increasing patient awareness regarding facial aesthetic options and a growing demographic willing to invest in personalized facial contouring solutions. The evolving consumer preferences across the Midwest indicate a robust trajectory for sustained market leadership through rising adoption.

Recent Developments

• In November 2025, AbbVie, through its Allergan Aesthetics division, secured FDA clearance for a new extended-duration formulation of JUVÉDERM VOLUMA XC. This advanced product was specifically engineered for high-volume midface augmentation, targeting patients experiencing significant malar volume deficiency. The development directly responded to the increasing demand within the United States for longer-lasting, single-session procedures for cheek restoration. This product launch represented a significant advancement in non-surgical options for enhancing cheek contours, providing patients with a durable solution for facial aesthetics.
• In February 2025, Crown Laboratories Inc., a skincare company based in the United States, completed the acquisition of Revance Therapeutics Inc. This strategic move aimed to enhance Crown Laboratories' market position in the aesthetics and skincare sector by integrating Revance's specialized aesthetic and therapeutic portfolio. Revance Therapeutics is recognized for its expertise in biotechnology relevant to the cheek augmentation market, particularly concerning advanced aesthetic solutions. The acquisition allowed Crown Laboratories to expand its product offerings within the United States market, addressing the growing demand for innovative options in facial volume restoration and contouring.
• In January 2025, Galderma released favorable interim outcomes from a clinical trial that explored the effectiveness of its injectable aesthetics portfolio. The study specifically investigated treatments for patients experiencing facial volume loss, a condition often associated with medication-driven weight loss. The trial demonstrated that a combined approach, utilizing the company's poly-L-lactic acid biostimulator and its hyaluronic acid fillers, effectively enhanced facial aesthetic appearance for cheek augmentation. This breakthrough research underscored Galderma's commitment to developing targeted solutions for the United States cheek augmentation market.
• In March 2024, Allergan Aesthetics, an AbbVie company, announced that the U.S. Food and Drug Administration granted approval for its prominent hyaluronic acid dermal filler. This approval specifically allowed for the improvement of moderate to severe temple hollowing in adults. Crucially, this expanded indication built upon the product's existing widespread use and established efficacy for deep injection in the cheek area, addressing age-related volume loss. This regulatory milestone further solidified the product's utility within the United States cheek augmentation market, offering practitioners an approved option for comprehensive facial rejuvenation.

Key Market Players

• AbbVie Inc.
• Merz Pharma GmbH & Co. KGaA
• Galderma SA
• Sientra, Inc.
• Stryker Corporation
• Sinclair
• Johnson & Johnson Services, Inc.
• Anika Therapeutics, Inc.
• Hanson Medical Inc.
• Zimmer Biomet

By Product	By Technique	By End User	By Region
Derma Fillers Implant Others	Surgical Non-surgical	Hospitals and Clinics Ambulatory Surgical Centers (ASCs) Specialty Clinics Others	Northeast Midwest South West

Report Scope:

In this report, the United States Cheek Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• United States Cheek Augmentation Market, By Product:

• Derma Fillers
• Implant
• Others

• United States Cheek Augmentation Market, By Technique:

• Surgical
• Non-surgical

• United States Cheek Augmentation Market, By End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

• United States Cheek Augmentation Market, By Region:

• Northeast
• Midwest
• South
• West